Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/19/1997 | EP0806935A2 Anti-adhesive active principles |
11/19/1997 | EP0806933A1 Formulations and methods for reducing skin irritation |
11/19/1997 | EP0806894A1 Micellar nanoparticles |
11/19/1997 | EP0765658B1 Use of salicylic acid derivatives for the treatment of striae |
11/19/1997 | EP0754188B1 Oligonucleotides with anti-cytomegalovirus activity |
11/19/1997 | EP0731807A4 N-2 substituted purines |
11/19/1997 | EP0720604B1 Conformationally locked nucleoside analogues |
11/19/1997 | EP0714418A4 Cosmetic melanins |
11/19/1997 | EP0682657B1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE |
11/19/1997 | EP0679157B1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
11/19/1997 | EP0598093B1 Quinuclidine derivatives as squalene synthetase inhibitors |
11/19/1997 | EP0566567B1 Antihypertensive benzopyran derivatives |
11/19/1997 | EP0536177B1 Thrombin inhibitors based on the amino acid sequence of hirudin |
11/19/1997 | EP0257102B1 Agents for treating neurophathy |
11/19/1997 | CN1165520A Phenylsubstituted 4-azasteroid fluoroderivatives |
11/19/1997 | CN1165510A Amine derivatives |
11/19/1997 | CN1165483A Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna) |
11/19/1997 | CN1165482A Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases |
11/19/1997 | CN1165481A Method and compositions for inhibiting protein kinases |
11/19/1997 | CN1165480A Liposome-formulation for treatment of viral diseases |
11/19/1997 | CN1165477A Delivery of solid drug compositions |
11/19/1997 | CN1165471A Antiparasitic composition for treating and protecting pets |
11/19/1997 | CN1165035A Antigen-antibody-recombination DNA composite type vaccin |
11/19/1997 | CN1165021A Medicine composition for treatment of tracheitis and asthma |
11/19/1997 | CN1165013A 微涂灵软膏 Micro-painted Ointment |
11/19/1997 | CN1165000A Method of reducing tissue damage associated with ischemia |
11/19/1997 | CN1164999A Benzopyran derivative and use of said benzopyran derivative for treating heart disease |
11/18/1997 | US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes |
11/18/1997 | US5688990 Forming chemical intermediates for azetidinone compounds that inhibit cholesterol biosynthesis for prevention of atherosclerosis |
11/18/1997 | US5688981 Ethylenediaminetriacetic acid and N-acyl ethylenediaminetriacetic acid silver chelating agents and surfactants |
11/18/1997 | US5688968 Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno 2,3-B!thiopyran-2-sulfonamide 7,7-dioxide |
11/18/1997 | US5688965 Bactericides |
11/18/1997 | US5688960 Substituted oximes, hydrazones and olefins useful as neurokinin antagonists |
11/18/1997 | US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity |
11/18/1997 | US5688956 Method for preparing N-methyl 2-(3-pyridyl) (1R,2R)-2-tetrahydrothiopyrancarbothioamide-1-oxide |
11/18/1997 | US5688955 Analgesics |
11/18/1997 | US5688954 Process for the preparation of substituted thiopyran-1-oxides |
11/18/1997 | US5688952 Vasoconstrictor intermediates |
11/18/1997 | US5688950 Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands |
11/18/1997 | US5688949 Pyrazolo 1,5-A!pyrimidine derivatives and anti-inflammatory agent containing the same |
11/18/1997 | US5688947 Production of purines via reductive formylation |
11/18/1997 | US5688946 Amino acid derivatives having renin inhibiting activity |
11/18/1997 | US5688945 Compounds |
11/18/1997 | US5688943 Cholecystokinin antagonist; antiulcer agents; psychological drugs; anxiolytic agents; controlling appetite |
11/18/1997 | US5688942 Process for preparing 2-isocephem derivatives |
11/18/1997 | US5688938 Calcium receptor-active molecules |
11/18/1997 | US5688926 Process of preparing etoposide phosphate and etoposide |
11/18/1997 | US5688925 Glycosylation or etherification as antitumor agents |
11/18/1997 | US5688924 Derivatives of 12,13-Epoxy-tylosin and processes of manufacture thereof |
11/18/1997 | US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis |
11/18/1997 | US5688829 Mixture containing dimethylacetamide, benzyl benzoate and ethyl oleate |
11/18/1997 | US5688828 Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents |
11/18/1997 | US5688825 Sulfonyloxysuccimides |
11/18/1997 | US5688824 Use of leflunomide to prevent or control xenograft rejection |
11/18/1997 | US5688823 Thiazolidine and oxazolidine derivatives their preparation and their medical use |
11/18/1997 | US5688820 Nervous system disorders; psychological disorders |
11/18/1997 | US5688819 Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
11/18/1997 | US5688818 Enzyme inhibitors |
11/18/1997 | US5688817 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
11/18/1997 | US5688815 Hydroxypyridinones |
11/18/1997 | US5688814 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
11/18/1997 | US5688813 2-phenyl-3-aroylbenzothiophenes |
11/18/1997 | US5688812 Method of inhibiting seborrhea and acne |
11/18/1997 | US5688811 Psychological disorders; nervous system disorders |
11/18/1997 | US5688809 5-heteroarylindole derivatives |
11/18/1997 | US5688807 Method for treating 5HT2B receptor related conditions |
11/18/1997 | US5688806 Antiinflammatory agents and central nervous system disorders |
11/18/1997 | US5688805 Inhibitors of tumor necrosis factor-a, treatment of septic shock, antiinflammatory, antiallergen |
11/18/1997 | US5688804 3-Benzylamino-2-phenyl-piperidine derivatives as substance P receptor antagonists |
11/18/1997 | US5688803 Tricyclic dicarbonyl derivatives |
11/18/1997 | US5688802 Treatment of alzheimer's disease, organic brain syndrome, parkinson's disease, senile dementia |
11/18/1997 | US5688801 Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
11/18/1997 | US5688799 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives |
11/18/1997 | US5688798 Psychotic illness such as schizophrenia |
11/18/1997 | US5688797 Treatment of acute central nervous system injury with piperazine derivatives |
11/18/1997 | US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods |
11/18/1997 | US5688795 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
11/18/1997 | US5688794 Administering metoclopramide |
11/18/1997 | US5688793 Pyridazino 4',5':3,4!pyrrolo- 2,1-a!-isoquinolines and the use thereof for preparing pharmaceutical preparations |
11/18/1997 | US5688791 Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv agent |
11/18/1997 | US5688790 Phenylpyrrole derivatives and their use as antipsychotic agents |
11/18/1997 | US5688789 PCP receptor ligands and the use thereof |
11/18/1997 | US5688788 N-substituted azaheterocyclic carboxylic acids and esters thereof |
11/18/1997 | US5688784 Method of suppressing appetite with vanadium complexes |
11/18/1997 | US5688782 Medicaments for treating respiratory disorders |
11/18/1997 | US5688781 Corticosteroids and antiinflammatory agents |
11/18/1997 | US5688780 Anticholesterol agents, cholesterol biosynthesis inhibition |
11/18/1997 | US5688773 Method of selectively destroying neoplastic cells |
11/18/1997 | US5688772 Quinoa saponin compositions and methods of use |
11/18/1997 | US5688771 Lipophilic oligopeptides with immunomodulating activity |
11/18/1997 | US5688765 Dry eyes |
11/18/1997 | US5688688 Vector for expression of a polypeptide in a mammalian cell |
11/18/1997 | US5688654 GABA a receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to GABAa receptor subtypes |
11/18/1997 | US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents |
11/18/1997 | US5688528 Oil-in water emulsions |
11/18/1997 | US5688524 Transdermal formulations for administering prazosin |
11/18/1997 | US5688523 Method of making a pressure sensitive skin adhesive sheet material |
11/18/1997 | US5688522 Ointment for wound treatment |
11/18/1997 | US5688521 Lactulose pastilles |
11/18/1997 | US5688520 Transmucosal delivery of melatonin for prevention of migraine |